Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $26.16
- 52-wk low
- $12.00
- Prev close
- $19.47
- Mkt cap
- $3.92B
- Beta
- 2.09
- P/S
- 12.7x
Smart money
Earnings
Earnings came in 30.8% below what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $58.9M | $94.0M | $71.7M | $70.9M |
| Cost of what it sold | $18.0M | $18.2M | $18.2M | $18.7M |
| Gross profit | $40.9M | $75.8M | $53.5M | $52.2M |
| What it spent | ||||
| Research and development | $24.1M | $23.7M | $21.8M | $23.6M |
| Sales and admin | $17.8M | $18.0M | $19.6M | $21.0M |
| Other operating costs | $24.0M | $23.9M | $24.9M | $26.8M |
| Total operating expenses | $65.9M | $65.5M | $66.2M | $71.4M |
| What was left | ||||
| Operating profit | -$25.0M | $10.3M | -$12.8M | -$19.2M |
| Interest on debt | $2.9M | $3.0M | $3.0M | $2.9M |
| Profit before tax | -$25.6M | $9.5M | -$13.6M | -$20.0M |
| Net profit | -$25.6M | $9.5M | -$13.6M | -$20.0M |
| EBITDA | -$18.1M | $16.9M | -$6.4M | -$14.4M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage is mixed
Tone of tracked coverage
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT
NeutralAug 21Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock
NeutralAug 20Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares
NeutralAug 20